SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Church who wrote (238)1/30/1997 4:47:00 PM
From: Peter Church   of 6136
 
FDA Advisory Committee meets on Feb 20, 1997. They release the agenda for the meeting 2 weeks prior to the meeting. I wonder what they will be talking about? Is there any way to scoop the Viracept approval date? An option holder would like to know.

Also of general interest to someone may be a review of the 4th Conference on Retroviruses by 5 MD's which can be heard by dialing 1800-707BETA. Viracept is noted as one of 3 potent PI's. Also, noted: Keep taking your medicine! i.e. the most tolerable regime is best. And, "...Viracept will be approved shortly..."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News